These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 181821)

  • 41. [From physiopathology to therapeutic principles in chronic obstructive bronchopneumopathy].
    Fleury B; Housset B; Derenne JP
    Rev Prat; 1985 May; 35(25):1471-6. PubMed ID: 4001794
    [No Abstract]   [Full Text] [Related]  

  • 42. [Contribution of pulmonary scintiscanning to the diagnosis of chronic obstructive bronchopneumopathy].
    Anastasatu C; Burnea D; Brăileanu A; Jienescu Z; Stere G; Bujor E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(4):223-8. PubMed ID: 188110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serum IgE levels in non-asthmatic children with chronic respiratory diseases].
    Endre L; Osváth P; Kelenhegyi K
    Orv Hetil; 1986 Jun; 127(25):1503-6. PubMed ID: 3725381
    [No Abstract]   [Full Text] [Related]  

  • 44. [Preliminary study of the deficiency of cellular immunity in patients with chronic obstructive pulmonary disease].
    Hu BX
    Zhonghua Yi Xue Za Zhi; 1985 Dec; 65(12):736-8. PubMed ID: 3938958
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 46. [The role of inflammation mediators in bronchial asthma and chronic obstructive pulmonary disease].
    Chciałowski A; Targowski T
    Pol Merkur Lekarski; 1999 Jan; 6(31):1-4. PubMed ID: 10344143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The immunological reactivity indices of patients with chronic nonspecific lung diseases].
    Linevskiĭ IuV; Galalu VV; Golubchenko OK; Chernykh SN; Kats LG
    Vrach Delo; 1990 Jul; (7):54-5. PubMed ID: 2238598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of guaiacolic ester of acetylsalicylic acid on spirometric and plethysmographic parameters in subjects with chronic obstructive bronchopneumopathy].
    Bonaduce D; Postiglione M; Ferrara N; Petretta M; De Caprio L; Rengo F
    Minerva Med; 1981 Feb; 72(7):333-7. PubMed ID: 7017482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic obstructive pulmonary disease and secretory IgA.
    Zinneman HH; Niewoehner DE; Goodsell MG
    Minn Med; 1980 Apr; 63(4):247-9. PubMed ID: 6966737
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chronic obstructive bronchopneumopathy after acute inhalation of sulfur anhydride. Apropos of a case].
    Ramakers M; Dubos C; Hazera P; Letourneux M; Brun J
    Rev Pneumol Clin; 1995; 51(6):343-7. PubMed ID: 8746024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ceruloplasmin levels in patients with chronic obstructive bronchopneumopathy].
    Lorenzo A; López Sáez JJ; Senra A; Millán J
    An Med Interna; 1991 Mar; 8(3):122-3. PubMed ID: 1893017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic obstructive bronchopneumopathy].
    Yernault JC; Vanatoru J
    Rev Med Brux; 1993 Apr; 14(4):99-101. PubMed ID: 8502862
    [No Abstract]   [Full Text] [Related]  

  • 53. [Study of the morphological changes of the liver in chronic obstructive bronchopneumopathy with decompensated heart disease].
    Băltăceanu OI; Tudose N; Munteanu M; Neamţu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(1):49-54. PubMed ID: 6106273
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chronic hepatitis].
    Cueni B; Schmid M
    Gastroenterol Fortbildungskurse Prax; 1975; 5():44-63. PubMed ID: 1083818
    [No Abstract]   [Full Text] [Related]  

  • 55. [Correlation of respiratory function and blood gas analysis in patients with obstructive bronchopneumopathy in acute or stabilized chronic phase].
    Schiavina M; Bernardi E; Faenza S; Festa C; Petrini F; Vissicchio D; Martinelli G
    Minerva Anestesiol; 1990 Oct; 56(10):1257-8. PubMed ID: 2290559
    [No Abstract]   [Full Text] [Related]  

  • 56. [Premises for a national program of prevention of chronic obstructive bronchopneumopathy (joint report)].
    Bercea O; Unteanu G; Velichi N
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(2):119-22. PubMed ID: 181825
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chronic obstructive bronchopneumopathy. Quality of the patients' life. May we hope?].
    Michard P; el Husseini F; Malépart MJ; Soubrat C; Kulpa M
    Soins; 1995 Jun; (597):29-34. PubMed ID: 7604312
    [No Abstract]   [Full Text] [Related]  

  • 58. [The relevance of serum-complement factors in chronic obstructive pulmonary disease (author's transl)].
    Lanzer G; Borkenstein J
    Acta Med Austriaca; 1981; 8(3):93-8. PubMed ID: 6911988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Questionnaire used in the study of the epidemiology of chronic obstructive bronchopneumopathy].
    Bungeţianu G; Duţu S; Maza D
    Ftiziologia; 1971; 20(3):325-30. PubMed ID: 5164067
    [No Abstract]   [Full Text] [Related]  

  • 60. [Nosographic and pathogenic considerations on a case of association of dermatomyositis and chronic autoimmune hepatitis].
    Buonanno G; Cione G; Perrone Donnorso R
    Policlinico Med; 1969; 76(3):117-29. PubMed ID: 5803023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.